Profil Penggunaan Antibiotik Pascapencanangan Penerapan Program Pengendalian Resistensi Antibiotik di Intensive Care Unit Rumah Sakit TNI-AL dr. Ramelan Surabaya
Abstract
Program Pengendalian Resistensi Antibiotik (PPRA) merupakan program wajib rumah sakit Indonesia sesuai Permenkes No. 8 tahun 2015. Rumkital dr. Ramelan Surabaya termasuk salah satu rumah sakit yang telah menerapkan PPRA. Tujuan penelitian ini adalah untuk mengetahui deskripsi kuantitatif-kualitatif pemakaian antibiotik, serta luaran klinis dan mikrobiologis yang teramati pascapencanangan penerapan PPRA di ICU Rumkital dr. Ramelan Surabaya. Desain penelitian adalah studi observasi cross-sectional yang dilakukan selama 3 bulan (Februari–Mei 2016) di ICU Rumkital dr. Ramelan. Deskripsi kuantitatif diamati menggunakan Days of Therapy (DOT/100 hari-pasien), deskripsi kualitatif menggunakan alur Gyssens. Pengamatan luaran klinis dilakukan terhadap infeksi nosokomial, mortalitas terkait infeksi, dan lama tinggal di ICU (Length of Stay/LOS). Pengamatan luaran mikrobiologis dilakukan terhadap pola penyebaran bakteri multiresisten. Hasil perhitungan jumlah konsumsi antibiotik didapatkan 151,63 DOT/100 hari-pasien. Penilaian kualitas antibiotik menunjukkan hasil 52,73% terapi tepat; 8,18% tidak tepat; 7,27% tanpa indikasi; 31,82% tidak tercapai kesepakatan antar penilai (κ=0,59; p<0,05). Infeksi nosokomial terbanyak yaitu Hospital Acquired Pneumonia (HAP)/Ventilator Associated Pneumonia (VAP), mortalitas terkait infeksi 44,68%; dan LOS rata-rata 7,17±1,9 hari (p<0,05). Belum ditemukan adanya insiden Methicillin-resistant Staphylococcus aureus (MRSA) ataupun Extended Spectrum Beta-Lactamase (ESBL), namun ditemukan dua kasus Multi Drug Resistant (MDR) Acinetobacter baumannii.
Kata kunci: Alur Gyssens, DOT, ICU, PPRA, resistensi antibiotik
Antibiotic Usage Profile after Antibiotic Stewardship Program Implementation in Intensive Care Unit of dr. Ramelan Naval Hospital Surabaya
Antibiotic Stewardship Program (ASP) is mandatory to all Indonesian hospitals, in accordance to the 2015 Minister of Health Decree No. 8. Dr. Ramelan Naval Hospital Surabaya is one among the many hospitals in Indonesia that has implemented the ASP. The study objective was to describe quantitative-qualitatively the use of antibiotics, along with clinical and microbiological outcomes observed in an Intensive Care Unit (ICU) after ASP implementation in dr. Ramelan Naval Hospital Surabaya. The design was a 3-month (February–May 2016) cross-sectional observational study. Quantitative description was reported using Days of Therapy (DOT)/100 patient-days, the qualitative description was reviewed using Gyssens’ flowchart. Clinical outcomes observed include nosocomial infection, infection-related mortality, and average length of stay (LOS). Microbiological outcome was observed through the occurences of multi-drug resistant organism. The results showed overall antibiotic use was 151.63 DOT/100 patient-days. Quality of antibiotic use were 52.73% definitely appropriate; 8.18% inappropriate regarding dose, intervals, durations, and timing; 7.27% no indication; and no mutual agreement in 31.82% (κ=0.59; p<0.05). Hospital Acquired Pneumonias (HAPs)/Ventilator Associated Pneumonias (VAPs) were the most observed nosocomial infection, infection-related mortality rate was 44.68%; and average LOS were 7.17±1.9 days (p<0.05). No incidents of Methicillin-resistant Staphylococcus aureus (MRSA) or Extended Spectrum Beta-Lactamase (ESBL) have been found, but there were two cases of Multi Drug Resistant (MDR) Acinetobacter baumannii.
Keywords: Antibiotic resistance, ASP, DOT, Gyssens’ flowchart, ICU
Keywords
Full Text:
PDF (Bahasa Indonesia)References
Lewis K. Platforms for antibiotic discovery. Nat Rev Drug Discov. 2013;12(5):371–87. doi: 10.1038/nrd3975
National Institute of Allergy and Infectious Disease. What is drug resistance? [Accessed on: 21st July 2016]. Available from: http://niaid.nih.gov
Septimus EJ, Owens RC. Need and potential of antimicrobial stewardship in community hospitals. Clin Infect Dis. 2011;53(1):S8–14. doi: 10.1093/cid/cir363
Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, et al. Implementing an antibiotic stewardship program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51–77. doi: 10.1093/cid/ciw118
Center for Disease Control and Prevention (CDC). Core elements of hospital antibiotic stewardship programs. Atlanta: US Department of Health and Human Services; 2014.
Lestari ES, Severin JA. Antimicrobial resistance in Indonesia: Prevalence, determinants and genetic basis. Erasmus MC: University Medical Center Rotterdam; 2009.
Mardiastuti HW, Karuniawati A, Kiranasari A, Kadarsih R. Emerging resistance pathogen: Recent situations in Asia, Europe, the United States of America, Middle East and Indonesia. Maj Kedokt Indones. 2007;57(3):75–9.
Duerink DO, Lestari ES, Hadi U, Nagelkerke NJ, Severin JA, Verbrugh HA, et al. Determinants of carriage of resistant Escherichia coli in the Indonesian population inside and outside hospitals. J Antimicrob Chemother. 2007;60(2):377–84. doi: 10.1093/jac/dkm197
Hadi U, Qiptiyah M, Paraton H. Problem of antibiotic use and antibiotic resistance in Indonesia: Are we really making progress? Indones J Trop Infect Dis. 2013;4(4):5–8. doi: 10.20473/ijtid.v4i4.222
Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: Comparison of defined daily dose and days of therapy. Clin Infect Dis. 2007;44(5):664–70. doi: 10.1086/511640
Septimus E. Antimicrobial stewardship–qualitative and quantitative outcomes: The role of measurement. Curr Infect Dis Rep. 2014;16(11):433. doi: 10.1007/s119 08-014-0433-x
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017; 45(3):486–552. doi: 10.1097/CCM.0000000000002255.
Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. 2012 infectious diseases society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):e132–73. doi: 10.1093/cid/cis346.
Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJC, Baron EJ, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(2):133–64. doi: 10.1086/649554
Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61–111. doi: 10.1093/cid/ciw353
Kaki R, Elligsen M, Walker S, Simor A, Palmay L, Daneman N. Impact of antimicrobial stewardship in critical care: A systematic review. J Antimicrob Chemother. 2011;66(6):1223–30. doi: 10.1093/jac/dkr137
Karanika S, Paudel S, Grigoras C, Kalbasi A, Mylonakis E. Clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs: A systematic review and meta-analysis. Antimicrob Agents Chemother. 2016;60(8):4840–52. doi: 10.1128/AAC.00825-16
Wagner LA, Tata AL, Fink JC. Patient safety issues in CKD: Core curriculum in 2015. Am J Kidney Dis. 2016;66(1):159–69. doi: 10.1053/j.ajkd.2015.02.343
Naidech AM. Intracranial hemorrhage. Am J Respir Crit Care Med. 2011;184(9):998–1006. doi: 10.1164/rccm.201103-0475CI
Hadi U, Duerink DO, Lestari ES, Nagelkerke NJ, Keuter M, Huis In’t Veld D, et al. Audit of antibiotic prescribing in two governmental teaching hospitals in Indonesia. Clin Microbiol Infect. 2008;14(7):698–707. doi: 10.1111/j.1469-0691.2008.02014.x.
Chan M, Ostermann M. Epidemiology of chronic dialysis patients in the intensive care unit. Crit Care Res Pract. 2013;10(5772):194–208. doi: 0.5772/52424
Society of Critical Care Medicine. Critical care statistics [Accessed on: 10th July 2017]. Available from: http://www.sccm.org/Communications/Pages/CriticalCareStats.aspx
Dombrovskiy V, Martin A, Sunderram J, Paz H. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med. 2007;35(5):1244–50. doi: 10.1097/01.CCM.0000261890.41311.E9
De Rosa S, Samoni S, Villa G, Ronco C. Management of chronic kidney disease patients in the intensive care unit: Mixing acute and chronic illness. Blood Purif. 2017;43(1–3):151–62. doi: 10.1159/000452650
Schuts EC, Hulscher MEJL, Mouton JW, Verduin CM, Stuart JWTC, Overdiek HWPM, et al. Current evidence on hospital antimicrobial stewardship objectives: A systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):847–56. doi: 10.1016/S1473-3099(16)00065-7.
McGregor JC, Furuno JP. Optimizing research methods used for the evaluation of antimicrobial stewardship programs. Clin Infect Dis. 2014;59(3):S185–92. doi: 10.1093/cid/ciu540
Rimawi RH, Mazer M a, Siraj DS, Gooch M, Cook PP. Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome. Crit Care Med. 2013;41(9):2099–107. doi: 10.1097/CCM.0b013e31828e9863.
DOI: https://doi.org/10.15416/ijcp.2018.7.1.30
Refbacks
- There are currently no refbacks.
Indonesian Journal of Clinical Pharmacy is indexed by
